Thiomersal: implementation of the warning statement relating to sensitisation

Current version

PDF iconPosition paper

Reference numberEMEA/CHMP/VWP/19541/2007
KeywordsThiomersal, preservative, vaccines, immunoglobulins, antimicrobial, organomercuric, summary of product characteristics (SmPC), sensitisation

This document provides guidance on the wording of the summary of product characterisitics and the package lefleat for the use of thiomersal in medicinal products with regard to sensitisation.

A 2016 review of this guideline concluded that it remains up-to-date and relevant.

How useful was this page?

Add your rating